|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Net Loss | |||||
| Adjustments to reconcile net loss to net cash used in operations: | |||||
| Depreciation | |||||
| Stock based compensation | |||||
| Non-cash expense for issuance of restricted stock grant awards | |||||
| Amortization of debt issuance costs | |||||
| Capital issued for interest expense | |||||
| Interest expense | |||||
| Accretion expense | |||||
| Settlement of asset retirement obligations | |||||
| Loss from change in fair value of derivative liability | |||||
| Loss from change in fair value of warrant liability | |||||
| Deferred tax expense | |||||
| Effect of changes in operating working capital items: | |||||
| Change in other assets | |||||
| Change in prepaid expenses | |||||
| Change in reclamation bonds accounts | |||||
| Change in derivative liability | |||||
| Change in accounts payable | |||||
| Cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of mineral properties | |||||
| Purchase of equipment | |||||
| Cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Capital issued for financing, net of share issuance costs | |||||
| Proceeds from royalty convertible debenture | |||||
| Proceeds from warrant private placement | |||||
| Royalty convertible debenture issuance costs | |||||
| Repayment of 2019 convertible notes | |||||
| Repayment of notes payable, related parties | |||||
| Cash provided by financing activities | |||||
| Change in cash during period | |||||
| Cash at beginning of period | |||||
| Cash at end of period | |||||
Loading...